Related Experiment Video
Updated: Jun 28, 2026
08:00
Intubation-mediated Intratracheal (IMIT) Instillation: A Noninvasive, Lung-specific Delivery System
Published on: November 17, 2014
[The Innovative Medicine Initiative (IMI)]
1Institut de Recherches Servier.
Medecine Sciences : M/S
|October 28, 2008
Summary
The Innovative Medicine Initiative (IMI) is a public-private partnership addressing drug discovery bottlenecks. It aims to improve efficacy and safety prediction, enhancing European biomedical science and patient therapies.
Area of Science:
- Biomedical Science
- Drug Discovery and Development
- Public-Private Partnerships
Context:
- Launched April 30th, 2008, the Innovative Medicine Initiative (IMI) is a collaboration between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
- Addresses critical bottlenecks in the pharmaceutical research and development pipeline.
Purpose:
- To identify and resolve challenges in drug discovery and development.
- To strengthen public-private partnerships within the European biomedical sector.
Summary:
- Focuses on key areas: efficacy and safety predictivity, knowledge management, and education/training.
- Aims to enhance Europe's attractiveness for biomedical research.
Impact:
- Facilitates the discovery of novel therapeutic strategies for patients.
- Reinforces the European biomedical science ecosystem.
Related Concept Videos
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...